Vinflunine clinical trials
How each study uses vinflunine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 21 Sept 2009 · Javlor · EMEA/H/C/000983 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
22 studies that test it; most in 2007 (6)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 6 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 10
Pierre Fabre Medicament (6) · Bristol-Myers Squibb (5) · SCRI Development Innovations, LLC (3) · Dr Anders Ullén (2) · Institute of Cancer Research, United Kingdom (1) · Spanish Oncology Genito-Urinary Group (1) · Veeda Oncology (1) · UNC Lineberger Comprehensive Cancer Center (1)
Often tested with
Tested in the same studies.
Sorafenib (1) · Ixabepilone (1) · Gemcitabine (1) · Carboplatin (1) · Cisplatin (1) · Rifampin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 2 phase 3 studies under way
Vinflunine is the comparator. A study of two new drugs counts under both.
- 1Erdafitinib · Janssen Research & Development, LLC
- 1Sacituzumab tirumotecan · Merck Sharp & Dohme LLC · next primary completion Jul 2029
Studies
Open first, then newest update. How each study uses vinflunine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedPhase 3Pierre Fabre MedicamentNCT01095003Written as Vinflunine plus CapecitabineHow we know
- Vinflunine in Hormone Refractory Prostate Cancer (HRPC)CompletedPhase 2SCRI Development Innovations, LLCNCT00545766Written as VinflunineHow we know
- A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)CompletedPhase 2Institute of Cancer Research, United KingdomNCT02057913Written as VinflunineHow we know
- A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionCompletedPhase 2Dr Anders UllénNCT02665039Written as VinflunineHow we know
- Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedPhase 3Pierre Fabre MedicamentNCT01091168Written as vinflunineHow we know
- A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedPhase 3Pierre Fabre MedicamentNCT02054338Written as Vinflunine+GemcitabineHow we know
- Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedPhase 3Pierre Fabre MedicamentNCT01953003Written as vinflunineHow we know
- Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractCompletedPhase 1Dr Anders UllénNCT01844947Written as VinflunineHow we know
- Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial CancerCompletedPhase 2Spanish Oncology Genito-Urinary GroupNCT01529411Written as VinflunineHow we know
- Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerCompletedPhase 3Pierre Fabre MedicamentNCT02347332Written as VinflunineHow we know
- Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)WithdrawnPhase 1/2Ligartis GmbHNCT02845050Written as VinflunineHow we know
- Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCTerminatedPhase 2UNC Lineberger Comprehensive Cancer CenterNCT00519831Written as vinflunineHow we know
- Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnPhase 2Alliance for Clinical Trials in OncologyNCT00450515Written as vinflunineHow we know
- A Study of the Alternative Administration of Ixabepilone and VinflunineCompletedPhase 1Bristol-Myers SquibbNCT00362830Written as vinflunine + ixabepiloneHow we know
- JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinCompletedPhase 2Pierre Fabre MedicamentNCT01599013Written as Vinflunine, GemcitabineHow we know
- First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based TherapyCompletedPhase 2/3Bristol-Myers SquibbNCT00389155Written as VinflunineHow we know
- A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced CancerWithdrawnPhase 1Bristol-Myers SquibbNCT00534807Written as VinflunineHow we know
- Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast CancerCompletedPhase 2SCRI Development Innovations, LLCNCT00284180Written as VinflunineHow we know
- Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung CancerCompletedPhase 2SCRI Development Innovations, LLCNCT00284154Written as VinflunineHow we know
- A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung CancerCompletedPhase 2Veeda OncologyNCT00251446Written as VinflunineHow we know
See all 22 studies that test vinflunine →
Given beside what is tested · 1 — vinflunine is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with vinflunine
- A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)RecruitingPhase 3Merck Sharp & Dohme LLCNCT07419295Written as VinflunineHow we know
- A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsActive, not recruitingPhase 3Janssen Research & Development, LLCNCT03390504Written as VinflunineHow we know
- Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadCompletedPhase 3Gilead SciencesNCT04527991Written as VinflunineHow we know
- A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)CompletedPhase 3Astellas Pharma Global Development, Inc.NCT03474107Written as VinflunineHow we know
- A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)CompletedPhase 3Merck Sharp & Dohme LLCNCT02256436Written as vinflunineHow we know
- A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]CompletedPhase 3Hoffmann-La RocheNCT02302807Written as VinflunineHow we know
- Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)Status unknownPhase 2/3Associació per a la Recerca Oncologica, SpainNCT01830231Written as VinflunineHow we know
Codes
What other systems call vinflunine · ClinicalTrials.gg INT004056
- MeSH (NLM) C111217vinflunineConfirmed NLM, Wikidata
- UNII (FDA) 5BF646324KVINFLUNINEConfirmed FDA, NLM, Wikidata
- Wikidata Q2195393vinflunineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61564VinflunineOne source FDA
- DrugBank DB11641One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C111217 | vinflunine | Confirmed NLM, Wikidata |
| UNII (FDA) | 5BF646324K | VINFLUNINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q2195393 | vinflunine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61564 | Vinflunine | One source FDA |
| DrugBank | DB11641 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.